Xanadu Bio

Private

PennsylvaniaHealthcare & Life Scienceshttps://xanadubio.com/

Last Round

Series B

Aug 27, 2025

Total Funding Raised

$22.99M

Company Overview

Xanadu Bio is a biotechnology company that develops a biodegradable poly(amine-co-ester) nanoparticle delivery platform for mRNA and other nucleic acid therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanoparticle deliverydrug delivery platformmRNA therapeuticsmRNA deliverydrug delivery techPACE platformnucleic acid deliveryintranasal vaccinetargeted drug deliverybiodegradable polymersnanomedicinemucosal immunitybiotech platformvaccine techbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xanadu Bio Comparables

Compare Xanadu Bio with similar companies based on industry and business-model similarity.

Xanadu Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Stradefy Biosciences	83%
Nanite, Inc.	83%
20Med Therapeutics	80%

View all Comparables

Xanadu Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Aug 27, 2025
Series A	Aug 16, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Bruce T.

Founder, Chief Executive Officer & Chair, Board of Directors

Founding Team

Taylor Feehley

Chief Operating Officer

Executive Team

Xanadu Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Xanadu Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xanadu Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersPennsylvania

Employee Range9

Year Founded2021

Last FundingAug 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.